tearlab corp
(TEAR:NASDAQ SE Consolidated Small Cap)

Executive Profile*

Background*

Dr. Julia A. Haller, M.D served as a Clinical Consultant and Adviser of Acuity Pharmaceuticals, Inc., since June 2005. Dr. Haller is a Principal investigator or Co-investigator on numerous grants dealing with treatment of cystoid macular edema, age-related macular degeneration, submacular surgery, diabetic retinopathy, retinopathy of prematurity, retinal venous occlusive disease and retinal infectious diseases. She is recognized as a vanguard in her field. Dr. Haller ... serves as a Visiting Professor and Lecturer all over the world. Dr. Haller has been the inaugural Robert Bond Welch, M.D. Professor of Ophthalmology at the Wilmer Eye Institute at Johns Hopkins since May 2006 and serves as its Director of the Retinal Surgical Fellowship Training Program. Dr. Haller is an Executive Editor for the American Journal of Ophthalmology. She serves as Co-Chairman and Member of Advisory Board of OptiMedica Corporation. She serves as a Member of Scientific Advisory Board of MacuSight, Inc. and Neurotech Pharmaceuticals, Inc. She serves on the editorial boards of RETINA, the Wilmer Retina Update, the Vitreous Society Journal, Evidence-Based Eye Care, The Johns Hopkins Women's Health Book, Retina Physician, and the Johns Hopkins Medical News Magazine. She served as Member of Scientific Advisory Board of OccuLogix Inc. from December 2005 to November 1, 2007. Dr. Haller is also Program Chair and President Elect of the American Society of Retina Specialists, a member of the Executive Committee of the Retina Society, and the Retina representative on the American Academy of Ophthalmology's Program Committee. She has published more than 180 papers in peer-reviewed literature, as well as 15 book chapters.

Report Data Issue

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Recently Viewed
TEAR:US	$10.07 USD	-0.21

COMPETITOR COMPENSATION